Stephen P Peters
Overview
Explore the profile of Stephen P Peters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
8632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Cooper C, Prince M, Ambale-Venkatesh B, Agarwal P, Backman M, et al.
Radiol Cardiothorac Imaging
. 2025 Jan;
7(1):e240053.
PMID: 39836055
Purpose To assess the repeatability of real-time cine pulmonary MRI measures of metronome-paced tachypnea (MPT)-induced dynamic hyperinflation and its relationship with chronic obstructive pulmonary disease (COPD) severity. Materials and Methods...
2.
Arjomandi M, Zeng S, Barjaktarevic I, Bleecker E, Bowler R, Criner G, et al.
Ann Am Thorac Soc
. 2024 Nov;
PMID: 39586032
Among tobacco-exposed persons with preserved spirometry (TEPS), we previously demonstrated that different lung volume indices, specifically elevated total lung capacity (TLC) versus elevated ratio of functional residual capacity-to-TLC (FRC/TLC), identify...
3.
Sharma R, Tiwari A, Kho A, Wang A, Srivastava U, Piparia S, et al.
BMC Pulm Med
. 2024 Nov;
24(1):553.
PMID: 39497092
Background: Bronchodilator response (BDR) is a measure of improvement in airway smooth muscle tone, inhibition of liquid accumulation and mucus section into the lumen in response to short-acting beta-2 agonists...
4.
Burnim M, Putcha N, LaFon D, Woo H, Azar A, Groenke L, et al.
Am J Respir Crit Care Med
. 2024 Oct;
211(2):215-221.
PMID: 39441116
Serum IgG deficiency is associated with morbidity in chronic obstructive pulmonary disease (COPD), but it is unclear whether concentrations in the lower end of the normal range still confer risk....
5.
Curtis J, Bateman L, Murray S, Couper D, Labaki W, Freeman C, et al.
Chronic Obstr Pulm Dis
. 2024 Aug;
11(5):444-459.
PMID: 39159077
Background: The biological mechanisms leading some tobacco-exposed individuals to develop early-stage chronic obstructive pulmonary disease (COPD) are poorly understood. This knowledge gap hampers development of disease-modifying agents for this prevalent...
6.
Ruvuna L, Hijazi K, Guzman D, Guo C, Loureiro J, Khokhlovich E, et al.
medRxiv
. 2024 Aug;
PMID: 39148837
Rationale: Identification and validation of circulating biomarkers for lung function decline in COPD remains an unmet need. Objective: Identify prognostic and dynamic plasma protein biomarkers of COPD progression. Methods: We...
7.
Xiang K, Sheehan K, Saha A, Koch A, Rackley J, Hicklin H, et al.
Sleep
. 2024 Aug;
47(10).
PMID: 39101404
No abstract available.
8.
Zhang W, Rice M, Hoffman K, Oromendia C, Barjaktarevic I, Wells J, et al.
JCI Insight
. 2024 Jun;
9(12).
PMID: 38912587
No abstract available.
9.
Baddour N, Paulin L, Gassett A, Woo H, Hoffman E, Newell Jr J, et al.
Ann Am Thorac Soc
. 2024 Apr;
21(9):1251-1260.
PMID: 38568439
It is unknown whether air pollution is associated with radiographic features of interstitial lung disease in individuals with chronic obstructive pulmonary disease (COPD). To determine whether air pollution increases the...
10.
Opron K, Begley L, Erb-Downward J, Li G, Alexis N, Barjaktarevic I, et al.
Am J Respir Crit Care Med
. 2024 Jan;
210(2):186-200.
PMID: 38261629
The airway microbiome has the potential to shape chronic obstructive pulmonary disease (COPD) pathogenesis, but its relationship to outcomes in milder disease is unestablished. To identify sputum microbiome characteristics associated...